CompoAtlas

COLODERME

COLODERME, licence 80027217: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Metanature
NPN or DIN-HM
80027217
Status
Active licence
Licence date
2 September 2011
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Calendula officinalis

Source : Fleur

4.0 %Not calculated

Non-medicinal ingredients

Palmitate d'isopropyle, Glycérine, Huile de coco fractionnée, Polyacrylate-13, Dipteryx Odorate Seed Oil, Poly(sorbate) 20, Eau purifiée, Behenyl alcohol, Colostrum bovin, Huile d'Argania Spinosa, Polyisobutylene, Noix du soudan, 3-acétyl-2-hydroxy-6-méthyl-pyran-4-one

PopulationAgeQuantity per servingFrequency
Adultes, adolescents et enfantsminimum: 2.0 Année(s)Not specifiedNot specified

Uses authorised in Canada

Le calendule est utilisé traditionnellement en phytothérapie pour aider à la cicatrisation des plaies. Le calendule est utilisé traditionnellement en phytothérapie pour aider à soulager les inflammations et les irritations de la peau.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80027217

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line